Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Lapatinib | 3.1623 | uM | 7 | 2500.00 | 1312.79 | 3066.00 | 4393.50 | 0.6979 | 0.6270 |
| BT-20 | 17-AAG | 0.031623 | uM | 7 | 2500.00 | 1312.79 | 1600.00 | 4393.50 | 0.3642 | 0.1202 |
| BT-20 | Erlotinib | 0.1 | uM | 7 | 2500.00 | 1312.79 | 4143.00 | 4393.50 | 0.9430 | 0.9338 |
| BT-20 | 0 | uM | 7 | 2500.00 | 1312.79 | 4365.00 | 4393.50 | 0.9935 | 0.9926 | |
| BT-20 | Linsitinib | 0.1 | uM | 7 | 2500.00 | 1312.79 | 4177.00 | 4393.50 | 0.9507 | 0.9428 |
| BT-20 | Lapatinib | 0.0016596 | uM | 7 | 2500.00 | 1312.79 | 4391.00 | 4393.50 | 0.9994 | 0.9994 |
| BT-20 | Lapatinib | 0.0033113 | uM | 7 | 2500.00 | 1312.79 | 4311.00 | 4393.50 | 0.9812 | 0.9784 |
| BT-20 | Linsitinib | 1 | uM | 7 | 2500.00 | 1312.79 | 4247.00 | 4393.50 | 0.9667 | 0.9615 |
| BT-20 | Lapatinib | 0.01 | uM | 7 | 2500.00 | 1312.79 | 4153.00 | 4393.50 | 0.9453 | 0.9364 |
| BT-20 | Linsitinib | 0.031623 | uM | 7 | 2500.00 | 1312.79 | 4245.00 | 4393.50 | 0.9662 | 0.9609 |
| BT-20 | 17-AAG | 1 | uM | 7 | 2500.00 | 1312.79 | 1324.00 | 4393.50 | 0.3014 | 0.0049 |
| BT-20 | 0 | uM | 7 | 2500.00 | 1312.79 | 4504.00 | 4393.50 | 1.0252 | 1.0287 | |
| BT-20 | Lapatinib | 0.1 | uM | 7 | 2500.00 | 1312.79 | 4214.00 | 4393.50 | 0.9591 | 0.9527 |
| BT-20 | Lapatinib | 0.031623 | uM | 7 | 2500.00 | 1312.79 | 4640.00 | 4393.50 | 1.0561 | 1.0636 |
| BT-20 | 0 | uM | 7 | 2500.00 | 1312.79 | 4367.00 | 4393.50 | 0.9940 | 0.9931 | |
| BT-20 | 0 | uM | 7 | 2500.00 | 1312.79 | 2.00 | 4393.50 | 0.0005 | -0.9758 | |
| BT-20 | 0 | uM | 7 | 5000.00 | 1243.75 | 0.00 | 7211.25 | 0.0000 | -1.0000 | |
| BT-20 | 0 | uM | 7 | 5000.00 | 1243.75 | 7337.00 | 7211.25 | 1.0174 | 1.0137 | |
| BT-20 | 17-AAG | 3.1623 | uM | 7 | 5000.00 | 1243.75 | 2374.00 | 7211.25 | 0.3292 | 0.2904 |
| BT-20 | Erlotinib | 0.01 | uM | 7 | 5000.00 | 1243.75 | 7439.00 | 7211.25 | 1.0316 | 1.0247 |
| BT-20 | Linsitinib | 3.1623 | uM | 7 | 5000.00 | 1243.75 | 6708.00 | 7211.25 | 0.9302 | 0.9437 |
| BT-20 | Erlotinib | 0.0033113 | uM | 7 | 5000.00 | 1243.75 | 7257.00 | 7211.25 | 1.0063 | 1.0050 |
| BT-20 | Lapatinib | 10 | uM | 7 | 5000.00 | 1243.75 | 2707.00 | 7211.25 | 0.3754 | 0.3590 |
| BT-20 | Linsitinib | 0.0033113 | uM | 7 | 5000.00 | 1243.75 | 7506.00 | 7211.25 | 1.0409 | 1.0318 |
| BT-20 | Erlotinib | 3.1623 | uM | 7 | 5000.00 | 1243.75 | 5645.00 | 7211.25 | 0.7828 | 0.8159 |